CGM | pharmaphorum

Skip to main content

Thursday 11 June 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

CGM

News

One Drop founder announces broad market CGM on Frontiers stage

One Drop founder announces broad market CGM on Frontiers sta...

One Drop founder Jeff Dachis brought his new product out of stealth mode at Frontiers Health -- a CGM for use beyond Type 1 diabetes.

Digital

participants

Everyday drug discovery: How tech expands the potential of c...

Discover how technology is making clinical trials more flexible and patient-friendly through tools like eCOA, eConsent, and wearables.

Views & Analysis

Shallow focus photo of a patient charts with focus on the middle

Digital Health Round-up: Can digital resolve NHS' data secur...

A round-up of this week's digital healthcare news. Marco Ricci reports.

Views & Analysis

glioblastoma

Digital Health Round-up - Is AI the future of cancer drug de...

Does artificial intelligence hold the key to cancer drug R&D?

News

one-drop-chrome

Is One Drop the start of a revolution in diabetes management...

One Drop Chrome now available in US and EU thanks to FDA and CE mark approval.

News

Red blood cells moving in blood vessels with depth of field.

Senseonics' implantable glucose monitor passes test

Company now looking to file for pre-marketing approval.

Editor's Picks

Servier wagers $2.65bn on Edgewise muscular dystrophy drug

ASCO26: AZ triplet makes waves in frontline liver cancer

ASCO26: Big win for Erleada in perioperative prostate cancer

Lilly licenses Hanmi GLP-2 drug in $1.26bn deal

First human trial backs AI-designed 'universal' vaccine

Oncology

Takeda’s Innovent deal bears fruit, with Teresa Bitetti and PK Morrow

Takeda’s Innovent deal bears fruit, with Teresa Bitetti and ...

Teresa Bitetti and PK Morrow share some of the highlights from Takeda’s data at the show as well as discussing how it fits into their larger strategy.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company